Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo

Molecular Therapy

Volumn 8, Issue 6, 2003, Pages 936-947

  Ziady, Assem Galal ^a   Gedeon, Christopher R ^b   Miller, Timothy ^b   Quan, William ^a   Payne, Jennifer M ^b   Hyatt, Susannah L ^b   Fink, Tamara L ^b   Muhammad, Osman ^b   Oette, Sharon ^b   Kowalczyk, Tomasz ^b   Pasumarthy, Murali K ^b   Moen, Robert C ^b   Cooper, Mark J ^b   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Copernicus Therapeutics Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA GALACTOSIDASE; LUCIFERASE; MACROGOL; NAKED DNA; NANOPARTICLE; PLASMID DNA; POLYLYSINE; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TISSUE LEVEL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME METABOLISM; EXPRESSION VECTOR; GENE LOCATION; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MOLECULAR STABILITY; MOUSE; MOUSE STRAIN; NONHUMAN; OPTIMAL DRUG DOSE; PARTICLE SIZE; RESPIRATORY EPITHELIUM; STAINING;

ANIMALIA; BACTERIA (MICROORGANISMS); VECTORS;

EID: 0347354994     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.07.007     Document Type: Article

References (32)

1. Boucher, R. C. (1999). Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103: 441-445.
2. Lee, E. R., et al. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7: 1701-1717.
3. Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., and Welsh, M. J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007.
4. Pollard, H., Remy, J. S., Loussouarn, G., Demolombe, S., Behr, J. P., and Escande, D. (1998). Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273: 7507-7511.
5. Cockett, M. J. (1999). Technology evaluation: cystic fibrosis therapy, Genzyme. Curr. Opin. Mol. Ther. 1: 279-283.
6. Knowles, M. R., et al. (1998). A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Hum. Gene Ther. 9: 249-269.
7. Zaloner, J., et al. (1997). Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 100: 1529-1537.
8. Liu, G., et al. (2003). Nanoparticles of compacted DNA transfect postmitotic cells. J. Biol. Chem. 278: 32578-32586.
9. Mannisto, M., et al. (2002). Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J. Controlled Release 83: 169-182.
10. Park, S., and Healy, K. E. (2003). Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)). Bioconjugate Chem. 14: 311-319.
11. Lee, H., Jeong, J. H., and Park, T. G. (2002). PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Controlled Release 79: 283-291.
12. Oupicky, D., Konak, C., Ulbrich, K., Wolfert, M. A., and Seymour, L. W. (2000). DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J. Controlled Release 65: 149-171.
13. Choi, Y. H., Liu, F., Park, J. S., and Kim, S. W. (1998). Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjugate Chem. 9: 708-718.
14. Kwoh, D. Y., et al, (1999). Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim. Biophys. Acta 1444: 171-190.
15. Ward, C. M., Pechar, M., Oupicky, D., Ulbrich, K., and Seymour, L. W. (2002). Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med. 4: 536-547.
16. Oupicky, D., Carlisle, R. C., and Seymour, L. W. (2001). Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 8: 713-724.
17. Kwok, K. Y., Park, Y., Yang, Y., McKenzie, D. L., Liu, Y., and Rice, K. G. (2003). In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensate. J. Pharm. Sci. 92: 1174-1185.
18. Kube, D. M., and Davis, P. B. (2003). Intracellular trafficking of nontargeted stabilized molecular conjugates in human airway epithelial cells. Mol. Ther. 7: S371.
19. Fajac, I., Briand, P., Monsigny, M., and Midoux, P. (1999). Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum. Gene Ther. 10: 395-406.
20. Kollen, W. J., et al. (1999). High-efficiency transfer of cystic fibrosis transmembrane conductance regulator cDNA into cystic fibrosis airway cells in culture using lactosylated polylysine as a vector. Hum. Gene Ther. 10: 615-622.
21. Klink, D. T., Chao, S., Glick, M. C., and Scanlin, T. F. (2001 ). Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells. Mol. Ther. 3: 831-841.
22. Ziady, A. G., Kelley, T., Milliken, E., Ferkol, T., and Davis, P. B. (2002). Functional evidence of CFTR gene transfer in nasal epithelium of CF mice following apical application of SEC receptor targeted DNA complexes. Mol. Ther. 5: 413-419.
23. Ziady, A. G., Ferkol, T., Dawson, D. V., Perlmutter, D. H., and Davis, P. B. (1999). Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. 274: 4908-4916.
24. Ziady, A. G., Ferkol, T., Gerken, T., Dawson, D. V., Perlmutter, D. H., and Davis, P. B. (1998). Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells. Gene Ther. 5: 1685-1697.
25. Felgner, P. L., et al. (1995). Improved cationic lipid formulations for in vivo gene therapy. Ann. N. Y. Acad. Sci. 772: 126-139.
26. Gautam, A., Densmore, C. L., Golunski, E., Xu, B., and Waldrep, J. C. (2001). Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol. Ther. 3: 551-556.
27. Gebhart, C. L., and Kabanov, A. V. (2001). Evaluation of polyplexes as gene transfer agents. J. Controlled Release 73: 401-416.
28. Gautam, A., Densmore, C. L., and Waldrep, J. C. (2001). Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther. 8: 254-257.
29. Chollet, P., Favrot, M. C., Hurbin, A., and Coll, J. L. (2002). Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4: 84-91.
30. Grassetti, D. R., and Murray, J. F. Jr (1967). Determination of sulfhydryl groups with 2,2′- or 4,4′-dithiodipyridine. Arch. Biochem. Biophys. 119: 41-49.
31. Hermanson, G. T. (1996). Bioconjugate Techniques, p. 148. Academic Press, New York.
32. Armitage, P., Berry, G., and Matthews, J. N. S. (2002). Statistical Methods in Medical Research, pp. 307-308. Blackwell Sci., London.